000 01323 a2200409 4500
005 20250511204701.0
264 0 _c19920421
008 199204s 0 0 eng d
022 _a0174-4879
040 _aNLM
_beng
_cNLM
100 1 _aGonzález-Martin, G
245 0 0 _aHeparin-induced hyperkalemia: a prospective study.
_h[electronic resource]
260 _bInternational journal of clinical pharmacology, therapy, and toxicology
_cNov 1991
300 _a446-50 p.
_bdigital
500 _aPublication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aAdolescent
650 0 4 _aAdult
650 0 4 _aAged
650 0 4 _aAged, 80 and over
650 0 4 _aChile
650 0 4 _aDiabetes Complications
650 0 4 _aFemale
650 0 4 _aHeparin
_xadministration & dosage
650 0 4 _aHumans
650 0 4 _aHyperkalemia
_xchemically induced
650 0 4 _aIncidence
650 0 4 _aMale
650 0 4 _aMiddle Aged
650 0 4 _aProspective Studies
650 0 4 _aRisk Factors
650 0 4 _aThromboembolism
_xprevention & control
650 0 4 _aTime Factors
700 1 _aDíaz-Molinas, M S
700 1 _aMartínez, A M
700 1 _aOrtiz, M
773 0 _tInternational journal of clinical pharmacology, therapy, and toxicology
_gvol. 29
_gno. 11
_gp. 446-50
999 _c1806619
_d1806619